Annual Shareholders Equity
$62.77 M
+$50.69 M+419.74%
31 December 2023
Summary:
Gossamer Bio annual stockholders equity is currently $62.77 million, with the most recent change of +$50.69 million (+419.74%) on 31 December 2023. During the last 3 years, it has fallen by -$257.92 million (-80.43%). GOSS annual shareholders equity is now -82.19% below its all-time high of $352.49 million, reached on 31 December 2019.GOSS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$54.14 M
-$27.39 M-33.60%
30 September 2024
Summary:
Gossamer Bio quarterly stockholders equity is currently $54.14 million, with the most recent change of -$27.39 million (-33.60%) on 30 September 2024. Over the past year, it has dropped by -$50.48 million (-48.25%). GOSS quarterly shareholders equity is now -88.73% below its all-time high of $480.26 million, reached on 31 March 2019.GOSS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GOSS Shareholders Equity Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +419.7% | -48.3% |
3 y3 years | -80.4% | -68.1% |
5 y5 years | +152.3% | -86.4% |
GOSS Shareholders Equity High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -80.4% | +419.7% | -68.1% | +186.2% |
5 y | 5 years | -82.2% | +152.3% | -87.1% | +186.2% |
alltime | all time | -82.2% | +152.3% | -88.7% | +145.1% |
Gossamer Bio Shareholders Equity History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $54.14 M(-33.6%) |
June 2024 | - | $81.53 M(+205.1%) |
Mar 2024 | - | $26.72 M(-57.4%) |
Dec 2023 | $62.77 M(+419.7%) | $62.77 M(-40.0%) |
Sept 2023 | - | $104.62 M(-266.6%) |
June 2023 | - | -$62.80 M(+120.7%) |
Mar 2023 | - | -$28.46 M(-335.6%) |
Dec 2022 | $12.08 M(-90.1%) | $12.08 M(-78.6%) |
Sept 2022 | - | $56.35 M(-442.3%) |
June 2022 | - | -$16.46 M(-154.6%) |
Mar 2022 | - | $30.16 M(-75.2%) |
Dec 2021 | $121.46 M | $121.46 M(-28.5%) |
Sept 2021 | - | $169.81 M(-23.1%) |
Date | Annual | Quarterly |
---|---|---|
June 2021 | - | $220.69 M(-18.9%) |
Mar 2021 | - | $272.08 M(-15.2%) |
Dec 2020 | $320.68 M(-9.0%) | $320.68 M(-13.8%) |
Sept 2020 | - | $372.10 M(-11.5%) |
June 2020 | - | $420.32 M(+37.2%) |
Mar 2020 | - | $306.46 M(-13.1%) |
Dec 2019 | $352.49 M(-393.6%) | $352.49 M(-11.6%) |
Sept 2019 | - | $398.87 M(-9.6%) |
June 2019 | - | $441.44 M(-8.1%) |
Mar 2019 | - | $480.26 M(-500.0%) |
Dec 2018 | -$120.07 M(+1649.8%) | -$120.07 M(-148.7%) |
Sept 2018 | - | $246.59 M(-3693.5%) |
Dec 2017 | -$6.86 M(+5478.9%) | -$6.86 M |
Dec 2016 | -$123.00 K | - |
FAQ
- What is Gossamer Bio annual stockholders equity?
- What is the all time high annual shareholders equity for Gossamer Bio?
- What is Gossamer Bio annual shareholders equity year-on-year change?
- What is Gossamer Bio quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Gossamer Bio?
- What is Gossamer Bio quarterly shareholders equity year-on-year change?
What is Gossamer Bio annual stockholders equity?
The current annual shareholders equity of GOSS is $62.77 M
What is the all time high annual shareholders equity for Gossamer Bio?
Gossamer Bio all-time high annual stockholders equity is $352.49 M
What is Gossamer Bio annual shareholders equity year-on-year change?
Over the past year, GOSS annual stockholders equity has changed by +$50.69 M (+419.74%)
What is Gossamer Bio quarterly stockholders equity?
The current quarterly shareholders equity of GOSS is $54.14 M
What is the all time high quarterly shareholders equity for Gossamer Bio?
Gossamer Bio all-time high quarterly stockholders equity is $480.26 M
What is Gossamer Bio quarterly shareholders equity year-on-year change?
Over the past year, GOSS quarterly stockholders equity has changed by -$50.48 M (-48.25%)